» Articles » PMID: 31849897

Expression Level of HIV-1 Vif Can Be Fluctuated by Natural Nucleotide Variations in the -Coding and Regulatory SA1D2prox Sequences of the Proviral Genome

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2019 Dec 19
PMID 31849897
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Vif is required for HIV-1 replication in natural target cells by counteracting host restriction factors, APOBEC3 (A3) proteins. We recently demonstrated that Vif expression level can be changed by naturally occurring single-nucleotide variations within SA1D2prox of the HIV-1 genome. We also found that levels for / mRNAs are inversely correlated. While amino acid sequence per se is critical for functionality, Vif expression level modulated by signal sequences in its coding region is likely to be important as well. There are two splicing sites in the region involved in expression. To reveal possible fluctuations of Vif-expression level, we examined SA1D2prox and gene by chimeric approaches using HIV-1 subtypes B and C with distinct anti-A3 activity. In this report, recombinant clones in subtype B backbone carrying chimeric sequences with respect to SA1D2prox/ and those within the -coding region were generated. Of these, clones containing -coding sequence of subtype C, especially its 3' region, expressed /Vif at a decreased level but did at an increased level for /Vpr. Clones with reduced /Vif level grew similarly or slightly better than a parental clone in weakly A3G-positive cells but more poorly in highly A3G-expressing cells. Three clones with this property were also tested for their A3-degrading activity. One of the clones appeared to have some defect in addition to the poor ability to express Vif. Taken all together, our results show that natural variations in the SA1D2prox and -coding region can change the Vif-expression level and affect the HIV-1 replication potential.

Citing Articles

Interferon-Regulated Expression of Cellular Splicing Factors Modulates Multiple Levels of HIV-1 Gene Expression and Replication.

Roesmann F, Muller L, Klaassen K, Hess S, Widera M Viruses. 2024; 16(6).

PMID: 38932230 PMC: 11209495. DOI: 10.3390/v16060938.


The Expression Level of HIV-1 Vif Is Optimized by Nucleotide Changes in the Genomic SA1D2prox Region during the Viral Adaptation Process.

Koma T, Doi N, Takemoto M, Watanabe K, Yamamoto H, Nakashima S Viruses. 2021; 13(10).

PMID: 34696508 PMC: 8537775. DOI: 10.3390/v13102079.


Expression and Characterization of Two DNA Constructs Derived from HIV-1-vif in and Mammalian Cells.

Zamani F, Bolhassani A, Shahbazi S, Faghih A, Sadat S Avicenna J Med Biotechnol. 2021; 13(3):131-135.

PMID: 34484642 PMC: 8377405. DOI: 10.18502/ajmb.v13i3.6369.


Commentary: Derivation of Simian Tropic HIV-1 Infectious Clone Reveals Virus Adaptation to a New Host.

Adachi A, Koma T, Doi N, Nomaguchi M Front Cell Infect Microbiol. 2020; 10:235.

PMID: 32500043 PMC: 7243179. DOI: 10.3389/fcimb.2020.00235.

References
1.
Emery A, Zhou S, Pollom E, Swanstrom R . Characterizing HIV-1 Splicing by Using Next-Generation Sequencing. J Virol. 2017; 91(6). PMC: 5331825. DOI: 10.1128/JVI.02515-16. View

2.
Nakashima M, Ode H, Kawamura T, Kitamura S, Naganawa Y, Awazu H . Structural Insights into HIV-1 Vif-APOBEC3F Interaction. J Virol. 2015; 90(2):1034-47. PMC: 4702671. DOI: 10.1128/JVI.02369-15. View

3.
Amendt B, Si Z, Stoltzfus C . Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol Cell Biol. 1995; 15(8):4606-15. PMC: 230701. DOI: 10.1128/MCB.15.8.4606. View

4.
Pollom E, Dang K, Potter E, Gorelick R, Burch C, Weeks K . Comparison of SIV and HIV-1 genomic RNA structures reveals impact of sequence evolution on conserved and non-conserved structural motifs. PLoS Pathog. 2013; 9(4):e1003294. PMC: 3616985. DOI: 10.1371/journal.ppat.1003294. View

5.
Okada A, Iwatani Y . APOBEC3G-Mediated G-to-A Hypermutation of the HIV-1 Genome: The Missing Link in Antiviral Molecular Mechanisms. Front Microbiol. 2017; 7:2027. PMC: 5165236. DOI: 10.3389/fmicb.2016.02027. View